Information communicated by Member States regarding State aid granted under Commission Regulation (EC) No 800/2008 declaring certain categories of aid compatible with the common market in application of Articles 87 and 88 of the Treaty (General Block Exemption Regulation)  (Text with EEA relevance)
Date: 2010-06-11
Institutions: European Commission
Subjects: State aid, control of State aid, industrial research, research and development








C_2010153EN.01005201.xml










11.6.2010   


EN


Official Journal of the European Union


C 153/52





Information communicated by Member States regarding State aid granted under Commission Regulation (EC) No 800/2008 declaring certain categories of aid compatible with the common market in application of Articles 87 and 88 of the Treaty (General Block Exemption Regulation)
(Text with EEA relevance)
2010/C 153/10







Reference number of the State Aid


X 824/09




Member State


Poland




Member State reference number


PL




Name of the Region (NUTS)


Warszawski (SRE 2001)
Article 107(3)(a)




Granting authority







Narodowe Centrum Badań i Rozwoju




Ul. Ks. I. Skorupki 4; 00-546 Warszawa




www.ncbir.gov.pl








Title of the aid measure


Pomoc na badania i rozwój dla LEK-AM Sp. z o.o. (9)




National legal basis (Reference to the relevant national official publication)


Art. 15 ust. 1 ustawy z dnia 8 października 2004 roku o zasadach finansowania nauki (Dz. U. Nr 238, poz. 2390 z późn. zm.); umowa nr KB/102/13666/IT1-C/U/09




Type of measure


Ad hoc aid — LEK-AM Sp. z o.o.




Amendment of an existing aid measure


—




Date of granting


6.2.2009




Economic sector(s) concerned


Manufacture of pharmaceutical preparations




Type of beneficiary


SME




Overall amount of the ad hoc aid awarded to the undertaking


PLZ 0,98 (in millions)




For guarantees


—




Aid Instrument (Article 5)


Grant




Reference to the Commission Decision


—




If co-financed by Community funds


—




Objectives


Maximum aid intensity in % or Maximum aid amount in national currency


SME-bonuses in %




Industrial research (Art. 31(2)(b))


60,00 %


10 %




Experimental development (Art. 31(2)(c))


35,00 %


10 %




Web link to the full text of the aid measure:
http://www.ncbir.pl/www/images/doc/initechI/pomoc/Decyzja%20LEK-AM%20102.pdf







Reference number of the State Aid


X 825/09




Member State


Poland




Member State reference number


PL




Name of the Region (NUTS)


Warszawski (SRE 2001)
Article 107(3)(a)




Granting authority







Narodowe Centrum Badań i Rozwoju




Ul. Ks. I. Skorupki 4; 00-546 Warszawa




www.ncbir.gov.pl








Title of the aid measure


Pomoc na badania i rozwój dla LEK-AM Sp. z o.o. (10)




National legal basis (Reference to the relevant national official publication)


Art. 15 ust. 1 ustawy z dnia 8 października 2004 roku o zasadach finansowania nauki (Dz. U. Nr 238, poz. 2390 z późn. zm.); umowa nr KB/143/13673/IT1-C/U/09




Type of measure


Ad hoc aid — LEK-AM Sp. z o.o.




Amendment of an existing aid measure


—




Date of granting


5.3.2009




Economic sector(s) concerned


Manufacture of pharmaceutical preparations




Type of beneficiary


SME




Overall amount of the ad hoc aid awarded to the undertaking


PLZ 0,76 (in millions)




For guarantees


—




Aid Instrument (Article 5)


Grant




Reference to the Commission Decision


—




If co-financed by Community funds


—




Objectives


Maximum aid intensity in % or Maximum aid amount in national currency


SME-bonuses in %




Industrial research (Art. 31(2)(b))


60,00 %


10 %




Experimental development (Art. 31(2)(c))


35,00 %


10 %




Web link to the full text of the aid measure:
http://www.ncbir.pl/www/images/doc/initechI/pomoc/Decyzja%20LEK-AM%20143.pdf







Reference number of the State Aid


X 826/09




Member State


Poland




Member State reference number


PL




Name of the Region (NUTS)


Warszawski (SRE 2001)
Article 107(3)(a)




Granting authority







Narodowe Centrum Badań i Rozwoju




Ul. Ks. I. Skorupki 4; 00-546 Warszawa




www.ncbir.gov.pl








Title of the aid measure


Pomoc na badania i rozwój dla LEK-AM Sp. z o.o. (11)




National legal basis (Reference to the relevant national official publication)


Art. 15 ust. 1 ustawy z dnia 8 października 2004 roku o zasadach finansowania nauki (Dz. U. Nr 238, poz. 2390 z późn. zm.); umowa nr KB/153/13668/IT1-C/U/09




Type of measure


Ad hoc aid — LEK-AM Sp. z o.o.




Amendment of an existing aid measure


—




Date of granting


5.3.2009




Economic sector(s) concerned


Manufacture of pharmaceutical preparations




Type of beneficiary


SME




Overall amount of the ad hoc aid awarded to the undertaking


PLZ 0,95 (in millions)




For guarantees


—




Aid Instrument (Article 5)


Grant




Reference to the Commission Decision


—




If co-financed by Community funds


—




Objectives


Maximum aid intensity in % or Maximum aid amount in national currency


SME-bonuses in %




Industrial research (Art. 31(2)(b))


60,00 %


10 %




Experimental development (Art. 31(2)(c))


35,00 %


10 %




Web link to the full text of the aid measure:
http://www.ncbir.pl/www/images/doc/initechI/pomoc/Decyzja%20LEK-AM%20153.pdf







Reference number of the State Aid


X 827/09




Member State


Poland




Member State reference number


PL




Name of the Region (NUTS)


Warszawski (SRE 2001)
Article 107(3)(a)




Granting authority







Narodowe Centrum Badań i Rozwoju




Ul. Ks. I. Skorupki 4; 00-546 Warszawa




www.ncbir.gov.pl








Title of the aid measure


Pomoc na badania i rozwój dla LEK-AM Sp. z o.o. (12)




National legal basis (Reference to the relevant national official publication)


Art. 15 ust. 1 ustawy z dnia 8 października 2004 roku o zasadach finansowania nauki (Dz. U. Nr 238, poz. 2390 z późn. zm.); umowa nr KB/154/13667/IT1-C/U/09




Type of measure


Ad hoc aid — LEK-AM Sp. z o.o.




Amendment of an existing aid measure


—




Date of granting


5.3.2009




Economic sector(s) concerned


Manufacture of pharmaceutical preparations




Type of beneficiary


SME




Overall amount of the ad hoc aid awarded to the undertaking


PLZ 1,13 (in millions)




For guarantees


—




Aid Instrument (Article 5)


Grant




Reference to the Commission Decision


—




If co-financed by Community funds


—




Objectives


Maximum aid intensity in % or Maximum aid amount in national currency


SME-bonuses in %




Industrial research (Art. 31(2)(b))


60,00 %


10 %




Experimental development (Art. 31(2)(c))


35,00 %


10 %




Web link to the full text of the aid measure:
http://www.ncbir.pl/www/images/doc/initechI/pomoc/Decyzja%20LEK-AM%20154.pdf







Reference number of the State Aid


X 828/09




Member State


Poland




Member State reference number


PL




Name of the Region (NUTS)


Warszawski (SRE 2001)
Article 107(3)(a)




Granting authority







Narodowe Centrum Badań i Rozwoju




Ul. Ks. I. Skorupki 4; 00-546 Warszawa




www.ncbir.gov.pl








Title of the aid measure


Pomoc na badania i rozwój dla LEK-AM Sp. z o.o. (13)




National legal basis (Reference to the relevant national official publication)


Art. 15 ust. 1 ustawy z dnia 8 października 2004 roku o zasadach finansowania nauki (Dz. U. Nr 238, poz. 2390 z późn. zm.); umowa nr KB/155/13669/IT1-C/U/09




Type of measure


Ad hoc aid — LEK-AM Sp. z o.o.




Amendment of an existing aid measure


—




Date of granting


5.3.2009




Economic sector(s) concerned


Manufacture of pharmaceutical preparations




Type of beneficiary


SME




Overall amount of the ad hoc aid awarded to the undertaking


PLZ 0,98 (in millions)




For guarantees


—




Aid Instrument (Article 5)


Grant




Reference to the Commission Decision


—




If co-financed by Community funds


—




Objectives


Maximum aid intensity in % or Maximum aid amount in national currency


SME-bonuses in %




Industrial research (Art. 31(2)(b))


60,00 %


10 %




Experimental development (Art. 31(2)(c))


35,00 %


10 %




Web link to the full text of the aid measure:
http://www.ncbir.pl/www/images/doc/initechI/pomoc/Decyzja%20LEK-AM%20155.pdf